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An individual catalytic component of calmodulin-independent adenylate cyclase has been isolated from bovine brain cor- 
tex. Affinity chromatography on an immunosorbent was used. The amino acid sequence of adenylate cyclase as well as 
the corresponding nucleotide sequence of the cDNA has been determined. cDNA of adenylate cyclase encodes a protein 
consisting of 834 amino acid residues and the signal peptide (19 amino acid residues). A series of adenylate cyclase iso- 
forms has been found. A homology between adenylate cyclases from bovine brain, E. coli and Bordetella pertussis has 
been revealed. 
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1. INTRODUCTION 
The adenylate cyclase system of the majority of 
eukaryotic cells is a membrane enzymatic complex 
functioning as a transmitter of hormonal signals 
into the cell. The system includes three com- 
ponents: receptor, GTP-binding proteins and the 
actual adenylate cyclase or catalytic component 
[l]. The latter has been poorly characterized thus 
far due to its instability and the small amounts oc- 
curring in tissues. 
This work deals with the isolation of calmodulin- 
independent adenylate cyclase from bovine brain 
and deciphering of its primary structure by parallel 
analysis of the amino acid sequence of the protein 
and nucleotide sequence of the corresponding 
cDNA (preliminary results in [2]). 
Correspondence address: V.M. Lipkin, Shemyakin Institute of 
Bioorganic Chemistry, USSR Academy of Sciences, ul. 
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2. MATERIALS AND METHODS 
Membranes of brain cortex were isolated according to [3] and 
membrane proteins were solubilized with 1% Lubrol PX or 
0.6% CHAPS. The adenylate cyclase preparation used for im- 
munization was obtained by chromatography on DEAE 
Sephacel [4]. Monoclonal antibodies were produced as in [5] by 
using mouse lines BALB/c for immunization [4]. Adenylate 
cyclase activity was determined according to [6]. 
Monoclonal antibodies were immobilized on CNBr- 
Sepharose. Affinity chromatography on immunosorbent was 
performed as described in [4] and on calmodulin-Sepharose as 
in [7]. For protein structural studies, adenylate cyclase was addi- 
tionally purified by SDS-PAGE with subsequent electroelution 
of the corresponding band 181. 
Adenylate cyclase (4 nmol) was digested with lysylendopep- 
tidase from Achromobacter liticus. Peptides were fractionated 
by gel filtration (Toyopearl HW40, 10% acetic acid in 20% 
acetonitrile) and the following reverse-phase HPLC (Ultra- 
sphere ODS, acetonitrile gradient in 0.1% trifluoroacetic acid). 
Cloning and hybridization were performed as in [9]. The 
nucleotide sequence of DNA was determined using the Maxam- 
Gilbert technique according to a solid-phase modification [lo]. 
3. RESULTS AND DISCUSSION 
The adenylate cyclase catalytic component was 
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isolated by chromatography of the Lubrol by gel filtration on Toyopearl HW40 followed by 
solubilizate of bovine cortex membranes on the im- HPLC on Ultrasphere ODS. A total of 18 in- 
munosorbent [4]. When preparing the immunosor- dividual peptides were isolated and the sequence of 
bent, use was made of monoclonal antibody Mab-1 228 amino acid residues was elucidated [4]. Accor- 
as a ligand. This antibody was obtained upon im- ding to the amino acid sequence of the peptide 
munization of mice with the adenylate cyclase (Lys)-Trp-Tyr-Asp-Ala-Lys, a mixture of oligode- 
preparation partially purified by DEAE-Sephacel oxyribonucleotide probes I 5 ‘AAXTGGTAZGAZ 
chromatography [4]. The antibody inhibits the en- GC was synthesized. These probes were employed 
zymatic activity of adenylate cyclase and is able to for screening a bovine brain cDNA clone library 
sorb enzyme after immobilization on protein A- produced with a statistical mixture of oligo- 
Sepharose. The preparation eluted from the im- nucleotides as primer (dispersed primer). Clone 
munosorbent contains one major polypeptide pAc 111 was found to give a positive hybridization 
(130 f 10 kDa) of molecular mass corresponding signal. To search for other clones, use was made of 
to that of adenylate cyclase [11,12] and two minor the method described in [2]. Clones pAc I, 5, 2.1, 
components (180 f 10 and 40 + 2 kDa). Unfor- 13, 18 and 32 were selected using probes I and II 
tunately, the eluted adenylate cyclase preparation from the clone library constructed via the use of 
lost its activity during the course of oligodeoxyribonucleotide probes III and IV as 
chromatography on the immunosorbent due to the primers, their structures corresponding to the 
severe conditions necessary for elution. To prove regions of clone pAc 111 cDNA. Simultaneously, 
that the 130 kDa protein represents a catalytic by employing probes III-V in the clone libraries 
component of the adenylate cyclase system, an an- produced using dispersed and oligo(dT) primers, 
tiserum was prepared against this protein electro- clones pAc 3,4,43,21.1,22,2.3 and 87 were deter- 
eluted from polyacrylamide. The resulting poly- mined. Another specific clone library was 
clonal antibodies effectively inhibit adenylate generated to disclose cDNA clones of the protein 
cyclase activity and after immobilization on pro- N-terminal region, probes VI and VII being ap- 
tein A-Sepharose are capable of binding the en- plied as primers revealing clones pAc 12, 19.2 and 
zyme from solution [4]. 19.4. 
It was shown that the monoclonal antibodies 
Mab-1 bind solely to the form of adenylate cyclase 
that does not bind to calmodulin-Sepharose. We 
therefore isolated the calmodulin-independent en- 
zyme form. 
Fig.1 depicts the location of the isolated 
adenylate cyclase cDNA fragments. The deci- 
phered nucleotide sequence of these fragments 
resulted in reconstitution of the entire cDNA struc- 
Immunoblotting shows that of three proteins 
(180, 130 and 40 kDa) the two of greater molecular 
masses cross-react with both the monoclonal an- 
tibody and polyclonal antibodies to the 130 kDa 
protein. 
For structural investigations we employed the 
homogeneous proteins (130 and 180 kDa) obtained 
from PAG by electroelution. The N-terminal se- 
quences of both polypeptides appeared to be iden- 
tical: Leu-Gln-Val-Asp-Ile-Val-Pro-Ser-Gln-Gly- 
Glu-Ile-Ser-Val- . . . 
To cleave the adenylate cyclase polypeptide 
chain of 130 kDa we applied lysylendopeptidase 
from A. liticus. The hydrolysate was fractionated 
Fig. 1. Location of cDNA fragments of isolated clones on a par- 
tial restriction map of adenylate cyclase cDNA. Filled rectangles 
indicate nucleotide probes used in cDNA cloning. The cDNA 
part encoding the adenylate cyclase is filled. 
Fig.2. Nucleotide sequence of cDNA encoding calmodulin-independent adenylate cyclase from bovine brain and the corresponding 
amino acid sequence of the enzyme polypeptide chain. The amino acid sequence derived from peptide analysis is underlined. Nine poten- 
tial sites of N-linked glycosylation are marked. 
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I- 68 TGATGTGI\GGCACTAlTTGTGGCCGGCGTGGTG~G~CACAGT~GGlTCTCACCCCCGCCCCCCG 
69- 187 CCCCWGCTCCCATCCCCAGTTCCATCAAAGCWACCCC~GCC~GCGC~~TCTCC~GTTGCTAGTGTGCT~~CTGG~CTGTCACTCATTCTCC~TCAGCGCGT~C~CT 
lb& 306 CTCGGCAGCGGCTGGCAMiAC~lTCTACAAAAATAATCGTACTCAGCCTGGC~TTGTCTGCCCCTA~TCTGTTGCTCTGCC~CGTCCACACTCGCTGC~~~CA~G 
4ATTTACCGCGGWGAACATCCCTCCCGGCCAGCAGATTACA ATG CTG CAA ACT kAG AAT CTC AK TGG ACT TTG TTT TTC CTG &A ACT GCA GTT TCT 
~t-Leu-Gl"-Thr-Lys-Asn-Leu-l1e-Trp-Thr-Leu-Phe-Phe-Leu-Gly-Thr-A1~-V~l-~r 
407- 4% 
l- 30 
CTG CM GTG GAT ATT GTT CCC AGC CM GGG W ATC AGC GTG GGA GAG TCC ARA TTC TTC CTG TGC CM GTG GCC GGA GAT GCC AAA GAT 
Leu-Gl"-Val-Asp-lle-Val-Pm-Ser-Gln-Gly-Glu-~le-ser-Val-Gly-Glu-Ser-Lys-Phe-Phe-Leu-Cys-G1n-Val-Ala-G1y-Asp-Al~-Lys-Asp- 
497- 586 
31- 60 
MA GAC ATC TCC TGG TTC TCG CCC AAC GGA GAG AAG CTC ACC CCA AAC CAG CAG CGG ATC TCG GTG GTA TGG AAC GAT GAC TCC TCC TCC 
LYs-Asp-I1~-Ser-T~p-Phe-S~r-P~-As"-Giy-G1u-LYs-Leu-Thr-Pro-Asn-Gln-G1n-Arg-lle-Ser-Val-Val-Trp-As"-Asp-Asp-Ser-Ser-Ser- 
587- 676 ACC CTC ACC ATC TM: AAC GCC MC ATC GAT GAT GCC G&C ATC TAC AAG TGT GTG GTC ACT GCG GAG WIT GGC ACC GAG TCA GA4 GCC ACG 
bl- w Thr-Leu-Thr-Ile-Tyr-Asn-Ala-As"-lle-Asp-Asp-Ala-Gly-Ile-Tyr-Lys-Cys-Val-Val-Thr-Ala-Glu-Asp-Gly-Thr-Glu-Ser-Glu-Ala-7hr- 
“ii: ::t 
767- 856 
12l- 1M 
GTC AM GTG MG ATC TTC CAG AAG CTC ATG TTC AAG AAC GCG CCA ACC CCA CAG GAG TTC AGG GRG GGA @.A GAT GCC GTG ATC GTG TGT 
Va1-Asn-Val-L_ys-lle-Phe-Gl"-Lys-Leu-bt-Phe-Lys-Asn-Ala-Pm-Thr-Pm-G1n-G1u-Phe-Arg-Glu-Gly-Glu-Asp-Ala-V~l-lle-Val-Cys- 
&AT GTG GTC AGC TCC CTC CCC CCA ACC ATC ATC TGG AAG CAC MA GGC CGA GAT GTC ATC CTG ARR AAA GAT GTC CGA TTC ATA GTC CTG 
Asp-Val-Val-Ser-Ser-Leu-Pm-Pm-Thr-lle-lle-T~p-Lys-~is-Lys-Gly-Arg-Asp-Val-~le-Leu-Lys-Lys-Asp-V~l-Arg-Phe-~le-V~l-Leu- 
%7- 946 ACC AAC AAC TAC CTC CAG ATC CGG GGC ATC RAG AAA ACA GAT GAG GGC ACT TAC CGC TGT GAG GGC AGG ATC CTT GCC CGC C&G GAG ATC 
151- 180 Thr-Asn-Asn-Tyr-Leu-Gl"-Ile-Aq-Gly-Ile-Lys-Lys-Thr-Asp-Glu-Gly-Thr-Tyr-Arg-Cys-Glu-Gly-Arg-Ile-Leu-Ala-Arg-Gly-Glu-~le- 
947-1036 
181- 210 
1037-1126 
Zll- 240 
AAC TTC PAG GAC ATT CAG GTC ATC GTG AAT GTG CCA CCC ACC GTC CAG GCC AGA CAG AGC ATC GTG 
6 
GCC ACC GCC AAC CTC GGC CAG 
As"-Phe-Lys-Asp-Ile-G1"-Val-lle-Val-As"-Va1-Pro-Pro-Thr-Val-Gln-Ala-Arg-G1"-Ser-Ile-Val s Alr-Thr-Ala-Asn-Leu-Gly-Gln- 
TCC GTC ACC CTC GTG TGC MC GCC GM, GGC TTC CCA GAG CCC ACC GTG AGC TGG ACG AAG GAC GGG GAG CAG ATA GAG AAT GAG GAG GAC 
Ser-Val-Thr-Leu-Val-Cys-Asn-Ala-G1u-Gly-Phe-Pm-G1u-Pm-Thr-Val-Ser-Trp-Thr-Lys-Asp-Gly-Glu-Gln-Ile-G1u-Asn-Glu-G1u-Asp- 
1127-1216 GAG AAG TAC CTG TTC AGC GAC GAC AGC TCC GAG CTG ACC ATC AGG AAG GTG GAC AAG AAC MC GAG GCT GAG TAC GTC TGC ATT GCC GAG 
241- 270 Glu-Lys-T_yr-Leu-Phe-Ser-Asp-Asp-Ser-Ser-Glu-Leu-Thr-lle-Arg-Lys-Val-Asp-Lys-Asn-Asp-Glu-Ala-Glu-Tyr-V~l-Cys-lle-Ala-Glu- 
1217-1306 
271- 300 
1307-l 3% 
301- 330 
AAC AAG GCG G&C GAG CAG MC GCG TX ATC CAC CTC MG GTC TTC GCA A&, CCC MA ATC ACC TAC GTA GAG 
6 
CAG ACT GCC ATG W 
Asn_Lys-Ala-Gly-Glu-Gln-Asp-Ala-Ser-lle-H~s-Leu-Lys-Val-Phe-Ala-Lys-Pro-Lys-Ile-Thr-Ty~-Val-Glu s Gln-Thr-Ala-#t-Glu- 
CTG GAG GM CAG GTC ACT CTT ACC TGT GAA GCC TCG GGA GAC CCC ATT CCC TCA ATC ACC TGG AG.4 ACA TCC ACC CGA ATC AGC AGT 
Leu-Glu-Glu-Gln-Va1-Thr-Leu-Thr-Cys-Glu-Ala-Ser-Gly-Asp-Pro-~le-Pm-Se~-~le-Thr-Trp-Arg-Thr-Ser-Thr-Arg Ile-SW-SW- 
1397-1486 GAA WV\ AAG GCT TCG TGG ACT CGA CCA GAG AAG CAA GAG ACC CTG GAC GGG CAC ATG GTG GTG CGC AU: CAC GCC CCC GTG TCG TCC CTG 
331- 3b0 G1u-G1u-Lys-Ala-Ser-Trp-Thr-Arg-Pro-Glu-LYs-Gln-G1u-Thr-Leu-Asp-Gly-His-Plet-Val-Val-Arg-Ser-H1s-Alr-Arg-Val-Ser-Ser-Leu- 
1487-1576 ACG CTG AAG AGC ATC CAG TAC ACC GAC GCC GGG GAG TAT GTC TGC ACT GCC AGC AAC ACC ATC GGC CAG G4C TCC Cffi TCC ATG TAC CTC 
361- 390 Thr-Leu-Lys-Ser-Ile-G1n-Tyr-Thr-Asp-Ala-Gly-G1u-Tyr-Val-Cys-Thr-Ala-Ser-As"-Thr-Ile-G1y-G1"-Asp-Ser-Gl"-Ser-#t-Tyr-Leu- 
1577-1666 
391- 420 
GAA GTG CAA TAT GCC CCC AAG CTG CAG GGC CCT GTG GCT GTG TAC ACT TGG GAG GGG MC CAG GTG ATC ACC TGC GAG GTG TTT GCC 
G1u-Va1-G1n-Tyr-Ala-Pm-Lys-Leu-Gln-Gly-Pm-Val-Ala-Val-Tyr-Thr-Trp-Glu-Gly-Asn-Gln-Val Ile-Thr-Cys-Glu-Val-Phe-Ala- 
1667-1756 
421- 450 
TAC CCC AGT MC ACT ATC TCG TGG TTC CGA GAC GGT CAG CTG CTG CCC AGC TAC AGC AAC ATC MG ATC TAC AAC ACC CCG TCC 
TYr-Ser-As"-lie-Lys-Ile-Ty~-As"-Thr-Pm_5~~ 
‘:W;l;84; 
1847-1936 
401- 510 
1937-2026 
511- 540 
TGT ACC GCA GTG AAC CGC ATC GG4 CAG G4G TCT TTG 
Cys-Thr-Ala-Val-As"-Arg-lie-Gly-Gin-Glu-SW-Lee- 
GAA TTC GTC CTT GTC CAA GLA &AT ACT CCA TCC TCA CCA TCC ATC MC CAG GTG GAG CCA TAC TCT AGC ACA GcA CAG GTG CM TTT GAT 
G~u-ph~-Va~_Leu-V~~-G1n-Al~-Asp-Thr-P~~-S~~-S~~-P~~-S~~-~l~-Asp-Gln-Val-Gl"-Pro-Tyr-Ser-Ser-Th~-Al~-Gln-Val-Gl"-ph~-ASP 
GAG CCA GAG GCC ACA GGC GGA GTG CCC ATC CTC MA TAC AAA GCT GA& TGG A@. GCA ATG GGX GAG GAG GTG TGG CAC TbC IUG TGG TAT 
G1u-Pm-G1u-Ala-Thr-Gly-G1y-Val-Pm-Ile-Leu-Lys-Tyr-Lys-Alr-G1u-Trp-Ara-Al~-llet-Gly-Glu-G1u-Val-Trp-His-Ser-Lys-T~- 
2027-2116 
541- 570 
2117-2206 
571- 600 
GAT GCC MG GM GCC AGC ATG GAG GGC ATT GTC ACC ATC GTG G&C CTC MG CCC GAG ACG ACG TAC GCA GTC CGG CTG GCG G&C CTC MC 
Asp-Ala-Lys-Glu-Ala-Ser-~t-Glu-Gly-ll~-V~l-Th~-~le-Val-Gly-L~~-Ly~-P~-Gl~-Th~-Thr-Tyr-Al~-Val-Arg-Leu-Ala-Ala-Leu-As"- 
ffiC AAG GGC CTG GGC GAG ATC AGC GCC GCC TCT GAG TTC AAG ACG CAG CCA GTC CGG GA4 CCC AGT GCA CCT AAG CTC MA GGG CAG ATG 
Gly-Lys-Gly-Leu-G1y-G1u-lle-Ser-Al.-Ala-Ser-G1u-Phe-Lys-Thr-G1n-Pm-Val-Arq-G1u-Pro-Scr-Ala-Pm-Lvs-Leu-G1u-Gly-G1"-l*t- 
2207-2296 
bOl- 630 
2297-2386 
631- 660 
2387-2476 
bbl- 690 
2477-2566 
691- 720 
GGA GAG GAT GGA MC TCT ATT AAG GTG AAG CTG ATC AAG CAA GAC GAC GGC GGC TCC CCC ATC CWI CAC TAC CTG GTC AAA TIC C&4 GCG 
Gly-Glu-Asp-Gly-Asn-Ser-lle-Lys-V~1-Lys-L~~-~le-Lys-G~n-Asp-Asp-Gly-Gly-Ser-Pm-~le-A~g-His-Tyr-Leu-Val-~s-Tyr-A~g-Al~- 
CTC TCC TCC GAG TGG MA CCA G4G ATC AGG CTC CCG TCT GGC AGT GAC CM GTC ATG CTC AAG TCC CTG &AC TGG AAT GCC GAG TAC GRG 
Leu-Scr-Ser-Glu-Trp-Lys-Pro-Glu-Ile-A~-L~~-P~-s~~-Gly-S~~-Asp-His-Val-~~-Leu-Lys-~r-Leu-Asp-Trp-As"-Al~-Glu-TYr-Glu- 
GTC TAT GTG GTG GCC GAG MC CA6 CAG "X kAG TCC MA GCG GCG CAC TTT GTG TTC AGG ACC TCG GCC CAG CCC ACA GCC ATC CCA GCC 
Val-Tyr-Val-Val-Ala-G1~-Asn-G1n-Gln-Gly-Lys-~~-Lys-Al~-Ala-His-Phe-V~l-Phe-A~g-Thr-S~~-Al~-Gln-Pro-Thr-Al~-~1e-Pm-Al~- 
GGC AGC CCC MC TCG GGC CTG AGC ACT GGC GCC ATC GTG GGC ATC CTC GTC GTG ACC TTC GTC CTG CTC CTG GTG GO2 GTG GAC GTC 
2567-2656 
721- 750 
2557-2746 
751- 780 
2747-2836 
781- 810 
2::::2;g 
2931-3049 
3050-3168 
3169-3287 
3288-34Ob 
3407-3525 
3526-3574 
ACC TGC TAC TTC CTG AAC AM TGT GGC CTG CTC ATG TGC ATT GCC GTC MC TTG TGT GGC Au GCC GGG CCC G&A GCC MC CGt MG MC 
Thr-Cys-Tyr-PhcLeu-Asn-Lys-Cys-Gly-Leu-L~~-~t-cys-Ile-Ala-v~l-Asn-Leu-Cys-G1y-Lys-Ala-Gly-Pm-Gly-Ala-Lys-Gly-Lys-AsP- 
ATG GM GM GGC MA GCG GCC TX TCG AAA GAT GAG TCC MG GAG CCT ATC GTG GAG GTG CGA ACG GAG GAG GAG CGG ACC CCG MT CAC 
I*t-G1u-Glu-Gly-Lys-Ala-Ala-Phe-Ser-Lys-~sp-Gl~-S~~-Lys-Gl~-P~-~l~-V~l-Gl~-Val-A~g-Th~-Glu-Glu-Glu-Aq-Th~-P~-AS"-His- 
GAC G&A GGG AAA CAC KG GAG CCG GAG ACC ACG CCG CTG ACG GAG CCC GA& AAG GGT CCC GTA GM GCA MG CCG GAG Au 'W KG 
Aw-G~Y-G~~-LYs-H~s-T~~-G~u-P~ Glu-Thr-Thr-pm-Leu-Thr-G1~-Pro-G1u-Lys-Gly-Pm-V~l-Glu-Ala-Lys-Pm-G~u-Thr-G~u-~- 
MG CCT GW CCA GCC MA GTC CAG MG GTC CCC MC G&T GCC KA CM ATA MG GTG GAGAGC AM GCG TGA TGGGTGACGAGACACCAGC 
~P~-A1~-Pm-Al~-Glu-V81-Gln-Thr-Val-Pm-Asn-Asp-Al~-Thr-G1n-Ilc-Lys-Val Glu-SW-Lys-Ala TER 
MAWIT~TAT~T~CAUIUOCTC~~TCTCT~CMT 
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ture (fig.2). The adenylate cyclase amino acid se- The amino acid sequence determined contains 
quence (1-14) derived from the cDNA structure 834 amino acid residues and has a molecular mass 
coincided with the N-terminal amino acid sequence of 91735 kDa. The validity of this structure is in- 
of the protein. dicated by the correspondence to the amino acid se- 
Triplet ATG (350-352) is an initiation codon: (i) 
this is the first ATG codon within the translation 
quences of the isolated peptides. Comparison of 
the cDNA structures of the isolated clones revealed 
frame behind terminator TAA (224-226); (ii) the some differences. Hence, together with clones 
structure of the signal peptide (Met-Leu-Gln-Thr- pAc 13,2.1 and 5, whose nucleotide sequences cor- 
Lys-Asn-Leu-Ile-Trp-Thr-Leu-Phe-Phe-Leu-Gly- respond to the peptide amino acid sequences, we 
Thr-Ala-Val-Ser) derived from cDNA corresponds isolated clones pAc 2.3 and 22 with the deletion of 
to the generalized structure for sequences of this 30 nucleotides (1405-1434), in which the triplet 
type 1131. CGG (2171-2173), coding for arginine, is sub- 
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Fig.3. Homologous regions of adenylate cyclase sequence from I, Succhuromyces cerevisioe (1693-1814); II, Bordefelkl perfussis 
(28-139); III, bovine brain (538-643, the given structure corresponds to that of pAc 111); IV, Escherichiu coli (l-95). Identical amino 
acid residues are boxed. 
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stituted by the sequence CAAGGG encoding the 
dipeptide Gln-Gly. We also isolated clone pAc 111 
with the insertion of 15 nucleotides (between 
nucleotides 2170 and 2171) encoding the peptide 
His-Ser-Pro-Leu-Pro. All this demonstrates the 
mRNA to be of several types encoding diverse iso- 
forms of adenylate cyclase. 
A considerable degree of structural homology of 
the bovine brain adenylate cyclase polypeptide 
chain region of 106 amino acid residues (538643) 
with the N-terminal regions of adenylate cyclases 
from Escherichia coli [14] (29 identical amino 
acids) and Bordetella pertussis [15] (33 identical 
amino acids) has been determined. At the same 
time, homology of the bovine and Saccharomyces 
cerevisiae [16] adenylate cyclases as well as en- 
zymes from E. coli and B. pertussis is not as evi- 
dent (16 and 12 amino acids, respectively) (fig.3). 
Since the N-terminal regions of adenylate cyclase 
from E. coli [ 141 and B. pertussis [151 are known to 
be responsible for the enzyme catalytic activity, the 
homologous regions of calmodulin-independent 
adenylate cyclase from bovine brain might also 
enter the catalytic site. This is proved by the 
presence of the sequence Ala-X-X-X-X-Gly-Lys- 
Ser (amino acid residues 665-672) following the 
homologous region in the adenylate cyclase struc- 
ture from bovine brain, being typical of the 
nucleotide-binding site [ 171. 
Amino acid sequence analysis of adenylate 
cyclase according to Kyte and Doolittle [18] re- 
vealed one distinct hydrophobic fragment con- 
sisting of amino acid residues 702-738, apparently, 
being transmembrane. The protein also contains 
several regions of less distinct hydrophobicity 
(185-228,562-583). Bovine brain adenylate cyclase 
is known to be a glycoprotein; nine potential 
glycosylating regions were found in the amino acid 
sequence (fig.2). These regions are mostly located 
in the mid- and C-terminal protein domain, some 
being probably outside the membrane. The loca- 
tion of the adenylate cyclase polypeptide chain 
relative to the plasma membrane is the aim of fur- 
ther studies. 
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